Cite

HARVARD Citation

    Fodil, S. et al. (2021). Data from French named patient program of quizartinib in relapsed/refractory acute myeloid leukemia. Leukemia & lymphoma. 62 (7), pp. 1756-1760. [Online]. 
  
Back to record